MedTech Acquisition Corp Analysis
MTACDelisted Stock | USD 10.55 0.03 0.28% |
MedTech Acquisition Corp is overvalued with Real Value of 8.91 and Hype Value of 10.55. The main objective of MedTech Acquisition delisted stock analysis is to determine its intrinsic value, which is an estimate of what MedTech Acquisition Corp is worth, separate from its market price. There are two main types of MedTech Acquisition's stock analysis: fundamental analysis and technical analysis.
The MedTech Acquisition stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and MedTech Acquisition's ongoing operational relationships across important fundamental and technical indicators.
MedTech |
MedTech Stock Analysis Notes
About 85.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.31. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. MedTech Acquisition Corp had not issued any dividends in recent years. MedTech Acquisition Corporation does not have significant operations. The company was incorporated in 2020 and is based in Greenwich, Connecticut. Medtech Acquisition is traded on NASDAQ Exchange in the United States. To find out more about MedTech Acquisition Corp contact Christopher Dewey at 908 391 1288.MedTech Acquisition Corp Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. MedTech Acquisition's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding MedTech Acquisition Corp or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
MedTech Acquisition is not yet fully synchronised with the market data | |
MedTech Acquisition has a very high chance of going through financial distress in the upcoming years | |
MedTech Acquisition Corp currently holds 2.37 M in liabilities with Debt to Equity (D/E) ratio of 1.77, which is about average as compared to similar companies. MedTech Acquisition Corp has a current ratio of 0.15, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about MedTech Acquisition's use of debt, we should always consider it together with its cash and equity. | |
MedTech Acquisition Corp currently holds about 69.18 K in cash with (2.74 M) of positive cash flow from operations. | |
Roughly 85.0% of MedTech Acquisition outstanding shares are owned by corporate insiders |
MedTech Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 83.86 M.MedTech Acquisition Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific MedTech Acquisition insiders, such as employees or executives, is commonly permitted as long as it does not rely on MedTech Acquisition's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases MedTech Acquisition insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Medtech Acquisition Sponsor Llc over a year ago Conversion by Medtech Acquisition Sponsor Llc of 6249999 shares of MedTech Acquisition | ||
Magnetar Financial Llc over a year ago Acquisition or disposition of MedTech Acquisition securities by Magnetar Financial Llc |
MedTech Acquisition Outstanding Bonds
MedTech Acquisition issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. MedTech Acquisition Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most MedTech bonds can be classified according to their maturity, which is the date when MedTech Acquisition Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Volcan Compania Minera Corp BondUSP98047AC08 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
US58506YAS19 Corp BondUS58506YAS19 | View | |
MEDTRONIC INC 4375 Corp BondUS585055BT26 | View | |
MEDTRONIC INC 4625 Corp BondUS585055BU98 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
US58502BAE65 Corp BondUS58502BAE65 | View |
MedTech Acquisition Predictive Daily Indicators
MedTech Acquisition intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of MedTech Acquisition stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About MedTech Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how MedTech Acquisition prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MedTech shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as MedTech Acquisition. By using and applying MedTech Stock analysis, traders can create a robust methodology for identifying MedTech entry and exit points for their positions.
MedTech Acquisition Corporation does not have significant operations. The company was incorporated in 2020 and is based in Greenwich, Connecticut. Medtech Acquisition is traded on NASDAQ Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding MedTech Acquisition to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
All Next | Launch Module |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in MedTech Stock
If you are still planning to invest in MedTech Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MedTech Acquisition's history and understand the potential risks before investing.
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Global Correlations Find global opportunities by holding instruments from different markets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |